Bavarian Biotech Report 2011/2012 (7MB) - Bio M
Bavarian Biotech Report 2011/2012 (7MB) - Bio M Bavarian Biotech Report 2011/2012 (7MB) - Bio M
IRIS Biotech GmbHPHARMA & CHEMICAL INDUSTRYContact:Dr. Thomas BruckdorferWaldershofer Str. 49-51D-95615 MarktredwitzPhone: +49 (0) 9231 9619-73Fax: +49 (0) 9231 9619-99E-Mail: info@iris-biotech.deInternet: www.iris-biotech.deKeywords: Natural Compounds, Combinatorial Chemistry, MedicinalChemistry, Drug Delivery, Drug Development, Peptide/Protein2011 – Celebrating 10 Years in Business:1. Starting Materials for Peptide Synthesis, Peptidomimetic and MedicinalChemistry (Protected Amino Acids, Coupling reagents, Linkers, resins)2. Reagents for PEGylation (improving solubility and pharmacokinetic propertiesof biopharmaceuticals and organic drug molecules)3. Reagents for Life Science Research (substrates for Drug InteractionStudies, Natural Products with biological & pharmacological activity, AminoAcid and Carbohydrates derivatives as enzyme substrates)4. Biocatalysis (immobilised enzymes, enzyme carriers, unusual and innovativeenzymes for modern biocatalytic synthesis of fine chemicals, opticalresolution of racemic mixtures; lipases and esterases for food industry andbiodiesel production)5. Contract Manufacturing of unusual derivatives with one or several chiralcentres.ITG Isotope Technologies Garching GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSContact:Dr. Richard HenkelmannLichtenbergstr. 1D-85748 GarchingPhone: +49 (0) 89 289139-46Fax: +49 (0) 89 289139-29E-Mail: info@itg-garching.deInternet: www.itg-garching.deKeywords: Drug Development, Clinical Diagnostics, Drug Delivery, Devices,Peptide/Protein, Small MoleculesITG Isotope Technologies Garching GmbH is responsible for all radio-isotoperelated development, production and logistics and provides products andservices to customers in medicine, industry and its sister companies withinthe ITM Group. ITG is managing the isotope sourcing from the global reactornetwork, operates the isotope processing facilities in Garching and holdsthe „radioactive materials production license”. ITG provides products suchas: Lutetium-177 n.c.a., Rhenium-188, Gallium-68, Ge-68/Ga-68 Generator,W-188/Re-188 Generator, Ac-225/Bi-213 Generator.iThera Medical GmbHBIOTECH DEVICES & REAGENTSContact:Christian WiestIngolstädter Landstr. 1D-85764 NeuherbergPhone: +49 (0) 89 3187-3973Fax: +49 (0) 89 3187-4170E-Mail: christian.wiest@ithera-medical.comInternet: www.ithera-medical.comKeywords: Nanobiotechnology, Drug Development, Devices, CardiovascularDiseases, Inflammation, OncologyiThera Medical develops and markets a novel in-vivo biomedical imagingtechnology, MSOT = multi-spectral opto-acoustic tomography. MSOT utilizesthe photo-acoustic effect to visualize and quantify anatomical, functionaland molecular information of living tissue. Today, MSOT allows the earlyand reliable validation of new substance efficacy in drug discovery (e.g., foroncology, neurology and cardiovascular problems). For the future, MSOTalso promises to become a valuable tool for clinical diagnostics.78
ITM Isotopen Technologien München AGPHARMA & CHEMICAL INDUSTRYKeywords: Drug Development, Drug Delivery, New Materials, Devices,Automation, Chip / Array Technology, Cardiovascular DiseasesSetting Standards with New Generation Therapies! The ITM Group providesa new generation of highly effective radioisotope therapies and integratedapplication systems to those oncological and endovascular patients who arecurrently very difficult or impossible to treat with conventional methods:ITM-Rhenium-SCT © : Skin cancer patients with large and difficult to treatlesions ITM-Rhenium-PTA © : Patients with progressed peripheral endovasculardisease, and cardiovascular patients with recurring in-stent restenosisITM-PRRT: Peptide Receptor Radioisotope Therapies: Oncological patientswith metastatic disease.Contact:Dr. Richard HenkelmannLichtenbergstr. 1D-85748 GarchingPhone: +49 (0) 8651 7678-0Fax: +49 (0) 8651 7678-20E-Mail: info@itm.agInternet: www.itm.agITM RP-München GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Cardiovascular Diseases, Small Molecules, Peptide/Protein,Devices, Drug Delivery, Clinical Diagnostics, Drug DevelopmentITM RP-München GmbH - Radiopharmazie München –is responsible forthe development of the portfolio and pipeline of radiopharmaceutical productsin oncology/personalized medicine.RPMs main focus are the so called Targeted or Peptide ReceptorRadioisotope Therapies, which have already proven their medical effectivenessand commercial viability in the treatment of various metastatic tumors.In this context an innovative peptide with a multistage targeting and internalizationmechanism has been licensed and has been brought into pre-clinicaldevelopment by RPM. First promising results in a wide variety ofvascularized tumors and metastatic melanoma could be obtained.Contact:Dr. Günter SchumacherLichtenbergstr. 1D-85748 GarchingPhone: +49 (0) 89 2891-3905Fax: +49 (0) 89 6283-6811E-Mail: info@radiopharmacy-munich.comInternet: www.radiopharmacy-munich.comKantarHealth GmbH – Clinical ResearchCROKeywords: Logistics, Clinical Research, Pharmacovigiliance, Oncology, MedicalWriting, Monitoring, AnalysisKantarHealth GmbH Clinical Research conducts phase I-IV clinical trials aswell as NIS world-wide. Our operations span local agencies in over seventycountries in Europe. KantarHealth GmbH combines more than 25 years ofCRO expertise in drug research with the development of innovative webbasedapplications in project and data management (InTrial and InDrums).Our services include: protocol and CRF design, eCRF solutions, feasibilityand site selection, investigators training, handling and completion of legaland ethical requirements, monitoring and site management, projectmanagement, implementation of risk management programs, data management,medical coding, quality assurance, statistical planning and analysis,medical writing.Contact:Siegfried FreytagLandsberger Str. 284D-80687 MünchenPhone: +49 (0) 89 5600-1421Fax: +49 (0) 89 5600-1590E-Mail: siegfried.freytag@kantarhealth.comInternet: www.kantarhealth.com79
- Page 29: one so called “innovation allianc
- Page 32 and 33: 4SC AGBIOTECH THERAPEUTICS & DIAGNO
- Page 34 and 35: Contact:Dr. Luc St-OngeFraunhoferst
- Page 36 and 37: Contact:Dr. Lars WassillWerkstr. 2D
- Page 38 and 39: Apceth GmbH & Co. KGBIOTECH THERAPE
- Page 40 and 41: Contact:Dr. Gundel HagerBahnhofstr.
- Page 42 and 43: Bernina Plus GmbHBIOTECH THERAPEUTI
- Page 44 and 45: Biontex Laboratories GmbHBIOTECH DE
- Page 46 and 47: Carl Zeiss MicroImaging GmbHBIOTECH
- Page 48 and 49: ChemDiv, Inc.CROContact:Dr. Anna Ni
- Page 50 and 51: conoGenetix biosciences GmbHBIOTECH
- Page 52 and 53: CoreLab Partners Europe GmbHCROCont
- Page 54 and 55: Davids Biotechnologie GmbHBIOTECH D
- Page 56 and 57: Dynamic BiosensorsBIOTECH DNA/PROTE
- Page 58 and 59: Contact:Uschi LangGoethestr. 4D-803
- Page 60 and 61: Eurofins MWG OperonBIOTECH DNA/PROT
- Page 62 and 63: FGK Clinical Research GmbHCROContac
- Page 64 and 65: GeneArt AGBIOTECHContact:Prof. Dr.
- Page 66 and 67: Contact:Dr. Korbinian GroteBayerstr
- Page 68 and 69: Contact:Peter Paul SchikoraMühlfel
- Page 70 and 71: Contact:Kurt MartinJosef-Engert-Str
- Page 72 and 73: ibidi GmbHBIOTECH DEVICES & REAGENT
- Page 74 and 75: Immumed GmbH -Gesellschaft für ang
- Page 76 and 77: INHECO GmbHBIOTECH DEVICES & REAGEN
- Page 80 and 81: KLIFOVET AGCROContact:Dr. Klaus Hel
- Page 82 and 83: LEUKOCARE AGBIOTECH DEVICES & REAGE
- Page 84 and 85: medicomp GmbHCROContact:Dr. med. ve
- Page 86 and 87: Contact:Dr. Erwin SoutschekFlorians
- Page 88 and 89: MLL Münchner Leukämie Labor GmbHB
- Page 90 and 91: multimmune GmbHBIOTECH THERAPEUTICS
- Page 92 and 93: NanoScape AGPHARMA & CHEMICAL INDUS
- Page 94 and 95: nexttec GmbHBIOTECH DNA/PROTEIN ANA
- Page 96 and 97: Contact:Michael AlmstetterAm Klopfe
- Page 98 and 99: PAN Biotech GmbHBIOTECH DEVICES & R
- Page 100 and 101: Pharma Stulln GmbHPHARMA & CHEMICAL
- Page 102 and 103: Phytochem Referenzsubstanzen GbRmbH
- Page 104 and 105: PreSens Precision Sensing GmbHBIOTE
- Page 106 and 107: Contact:Dr. Torsten NeuefeindBunsen
- Page 108 and 109: Ridom GmbHBIOTECH BIOINFORMATICSCon
- Page 110 and 111: SERVIER Deutschland GmbHPHARMA & CH
- Page 112 and 113: SSS International Clinical Research
- Page 114 and 115: TILL Photonics GmbHBIOTECH DEVICES
- Page 116 and 117: Tripos InternationalBIOTECH BIOINFO
- Page 118 and 119: vertis Biotechnologie AGBIOTECH DNA
- Page 120 and 121: Wilex AGBIOTECH THERAPEUTICS & DIAG
- Page 124: Where the future becomes realityHOT
IRIS <strong><strong>Bio</strong>tech</strong> GmbHPHARMA & CHEMICAL INDUSTRYContact:Dr. Thomas BruckdorferWaldershofer Str. 49-51D-95615 MarktredwitzPhone: +49 (0) 9231 9619-73Fax: +49 (0) 9231 9619-99E-Mail: info@iris-biotech.deInternet: www.iris-biotech.deKeywords: Natural Compounds, Combinatorial Chemistry, MedicinalChemistry, Drug Delivery, Drug Development, Peptide/Protein<strong>2011</strong> – Celebrating 10 Years in Business:1. Starting Materials for Peptide Synthesis, Peptidomimetic and MedicinalChemistry (Protected Amino Acids, Coupling reagents, Linkers, resins)2. Reagents for PEGylation (improving solubility and pharmacokinetic propertiesof biopharmaceuticals and organic drug molecules)3. Reagents for Life Science Research (substrates for Drug InteractionStudies, Natural Products with biological & pharmacological activity, AminoAcid and Carbohydrates derivatives as enzyme substrates)4. <strong>Bio</strong>catalysis (immobilised enzymes, enzyme carriers, unusual and innovativeenzymes for modern biocatalytic synthesis of fine chemicals, opticalresolution of racemic mixtures; lipases and esterases for food industry andbiodiesel production)5. Contract Manufacturing of unusual derivatives with one or several chiralcentres.ITG Isotope Technologies Garching GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSContact:Dr. Richard HenkelmannLichtenbergstr. 1D-85748 GarchingPhone: +49 (0) 89 289139-46Fax: +49 (0) 89 289139-29E-Mail: info@itg-garching.deInternet: www.itg-garching.deKeywords: Drug Development, Clinical Diagnostics, Drug Delivery, Devices,Peptide/Protein, Small MoleculesITG Isotope Technologies Garching GmbH is responsible for all radio-isotoperelated development, production and logistics and provides products andservices to customers in medicine, industry and its sister companies withinthe ITM Group. ITG is managing the isotope sourcing from the global reactornetwork, operates the isotope processing facilities in Garching and holdsthe „radioactive materials production license”. ITG provides products suchas: Lutetium-177 n.c.a., Rhenium-188, Gallium-68, Ge-68/Ga-68 Generator,W-188/Re-188 Generator, Ac-225/Bi-213 Generator.iThera Medical GmbHBIOTECH DEVICES & REAGENTSContact:Christian WiestIngolstädter Landstr. 1D-85764 NeuherbergPhone: +49 (0) 89 3187-3973Fax: +49 (0) 89 3187-4170E-Mail: christian.wiest@ithera-medical.comInternet: www.ithera-medical.comKeywords: Nanobiotechnology, Drug Development, Devices, CardiovascularDiseases, Inflammation, OncologyiThera Medical develops and markets a novel in-vivo biomedical imagingtechnology, MSOT = multi-spectral opto-acoustic tomography. MSOT utilizesthe photo-acoustic effect to visualize and quantify anatomical, functionaland molecular information of living tissue. Today, MSOT allows the earlyand reliable validation of new substance efficacy in drug discovery (e.g., foroncology, neurology and cardiovascular problems). For the future, MSOTalso promises to become a valuable tool for clinical diagnostics.78